CASHIN RICHARD M JR 4
4 · AdaptHealth Corp. · Filed Mar 12, 2026
Research Summary
AI-generated summary of this filing
AdaptHealth (AHCO) 10% Owner Richard Cashin Buys 2.05M Shares
What Happened
Richard M. Cashin Jr., reported as a 10% owner, made open-market purchases of a total of 2,046,691 shares of AdaptHealth Corp. (AHCO) across March 10–12, 2026. The filing reports weighted-average prices of $9.73 for most lots; the three reported aggregate cash amounts are $7,982,671, $5,222,307 and $6,707,170, for a combined spend of about $19.91 million. These were purchases (buying stock), which investors typically view as a bullish signal from an insider or affiliated investor.
Key Details
- Transaction dates: March 10, 2026; March 11, 2026; March 12, 2026.
- Reported share totals and amounts: 820,528 shares ($7.98M), 536,827 shares ($5.22M), 689,336 shares (~$6.71M) — total 2,046,691 shares for ~$19.91M.
- Reported prices are weighted averages; footnotes show trades executed across price ranges (roughly $9.55–$9.95 depending on lot). The filer can provide per-trade price breakdowns on request.
- Shares were purchased and are held by OEP AHCO Investment Holdings, VI LLC (Investor). Footnotes explain that Investor is owned by multiple One Equity Partners funds and that the six‑member investment committee of OEP VII GP acts by majority vote, which must include Richard Cashin. Accordingly, Cashin may be deemed to have voting and investment discretion (and beneficial ownership) of the reported securities; the reporting parties disclaim beneficial ownership except to the extent of pecuniary interest.
- Filing: Form 4 filed March 12, 2026 covering trades March 10–12; filing appears timely based on reported dates.
- Shares owned after transaction: Not specified in the supplied excerpt of the filing.
Context
- These purchases were made by an institutional vehicle (the Investor and affiliated One Equity Partners funds) with Richard Cashin having investment/voting discretion — this is institutional insider-affiliated buying rather than a routine executive payroll or option exercise.
- The filing includes typical weighted-average pricing footnotes and a remark that EDGAR codes for the OEP entities were not available at time of filing; the Form 4 may be amended to formally list those entities as reporting persons.
Note: This summary is factual and based on the Form 4 filing; it does not speculate on the motivations behind the purchases.
Insider Transaction Report
Form 4
CASHIN RICHARD M JR
10% Owner
Transactions
- Purchase
Common Stock
[F1][F2][F3]2026-03-10$9.73/sh+820,528$7,982,671→ 14,638,708 total(indirect: See footnotes) - Purchase
Common Stock
[F4][F2][F3]2026-03-11$9.73/sh+536,827$5,222,307→ 15,175,535 total(indirect: See footnotes) - Purchase
Common Stock
[F5][F2][F3]2026-03-12$9.73/sh+689,336$6,707,170→ 15,864,871 total(indirect: See footnotes)
Footnotes (5)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.58 to $9.95, inclusive. The reporting persons undertake to provide to AdaptHealth Corp., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]These securities are held directly by OEP AHCO Investment Holdings, VI LLC ("Investor"). Investor is owned by One Equity Partners VII, L.P., a Cayman Islands exempted limited partnership ("OEP VII LP"), One Equity Partners VII-A, L.P., a Cayman Islands exempted limited partnership ("OEP VII-A LP"), One Equity Partners VII-B, L.P., a Delaware limited partnership ("OEP VII-B LP"), OEP VII Project A Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A LP") and OEP VII Project A-I Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A-I LP" and, together with OEP VII LP, OEP VII-A LP, OEP VII-B LP and OEP VII Project A LP, the "Parallel Funds"). The general partner of each of the Parallel Funds is OEP VII General Partner, L.P., a Cayman Islands exempted limited partnership ("OEP VII GP"), and the general partner of OEP VII GP is OEP VII GP, L.L.C., a Cayman Islands limited liability company ("OEP VII GP LLC").
- [F3](Continued from Footnote 2) The six member investment committee of OEP VII GP acts by majority vote, which majority must include Richard Cashin. Accordingly, Richard Cashin may be deemed to have voting and investment discretion, and beneficial ownership, of the reported securities. Each of the reporting persons disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.
- [F4]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.64 to $9.75, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F5]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.55 to $9.75, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Signature
/s/ Richard Cashin|2026-03-12